TXMD - TherapeuticsMD - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TherapeuticsMD's activity chart (see below) currently has 77 price targets and 93 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 9.32% with an average time for these price targets to be met of 89.33 days.

Most recent stock forecast was given by from SCOTIABANK on 17-Aug-2023. First documented stock forecast 21-Sep-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 17-May-2022

$5

$2.89 (136.97%)

3 years 1 months 18 days ago
(17-Aug-2023)

7/8 (87.5%)

$1.35 (36.99%)

684

Hold Since 07-Jun-2022

$125

4 years 3 months 28 days ago
(07-Jun-2022)

0/4 (0%)

$110.5 (762.07%)

Buy Since 10-Apr-2017

$450

5 years 2 months ago
(05-Aug-2021)

0/5 (0%)

$331 (278.15%)

Buy Since 10-Oct-2016

$250

$247.95 (12095.12%)

$300

5 years 4 months 29 days ago
(06-May-2021)

0/10 (0%)

$194.5 (350.45%)

Buy Since 04-Apr-2016

5 years 5 months 28 days ago
(07-Apr-2021)

0/8 (0%)

$202 (67.79%)

Show more analysts

Please expand the browser size to see the chart

What is TXMD (TherapeuticsMD) average time for price targets to be met?

On average it took 89 days for the stock forecasts to be reached, with an average price target met ratio of 9.32%.

Which analyst most recently updated their price target on TXMD (TherapeuticsMD)?

Which analyst has the most public recommendations on TXMD (TherapeuticsMD)?

has 0 price targets and 0 ratings on TXMD

Which analyst is the currently most bullish on TXMD (TherapeuticsMD)?

William Tanner with the highest potential upside of $1347.95

Which analyst is the currently most reserved on TXMD (TherapeuticsMD)?

Jay Olson with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?